Novelix Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 44.73 | 36.92 | 25.19 |
| Operating Expense | 42.61 | 35.61 | 23.91 |
| Net Profit | 1.56 | 1.18 | 0.91 |
| Net Profit Margin | 3.49% | 3.20% | 3.61% |
| Earning Per Share | 0.57 | 0.49 | 0.43 |
| EBIDTA | 2.21 | 1.63 | 1.29 |
| Effective Tax Rate | 18.40% | 20% | 25.78% |
Particulars
Sep 2026
Revenue44.73
Operating Expense42.61
Net Profit1.56
Net Profit Margin3.49
Earning Per Share0.57
EBIDTA2.21
Effective Tax Rate18.40
